Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker‐Positive, Sporadic Parkinson's Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
MDS clinical diagnostic criteria for Parkinson's disease
10.1002/mds.26424 · 2015 · External reference
Parkinson's disease: the quintessential neuropsychiatric disorder
10.1002/mds.23664 · 2011 · External reference
Neuropsychiatric disorders in Parkinson's disease
10.1177/17562864251356062 · 2025 · External reference
Range of neuropsychiatric disturbances in patients with Parkinson's disease
10.1136/jnnp.67.4.492 · 1999 · External reference
The neuropsychiatry of Parkinson's disease: advances and challenges
10.1016/s1474-4422(21)00330-6 · 2022 · External reference
Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease
10.1016/j.parkreldis.2015.03.024 · 2015 · External reference
Impact of neuropsychiatric symptoms on the quality of life of subjects with Parkinson's disease
10.3233/jpd-150597 · 2015 · External reference
The neuropsychiatry of Parkinson disease: a perfect storm
10.1016/j.jagp.2019.03.002 · 2019 · External reference
The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease
10.1136/jnnp.2008.166959 · 2009 · External reference
Baseline prevalence and longitudinal evolution of non‐motor symptoms in early Parkinson's disease: the PPMI cohort
10.1136/jnnp-2017-316213 · 2018 · External reference
Longitudinal evolution of non‐motor symptoms according to age at onset in early Parkinson's disease
10.1016/j.jns.2020.117157 · 2020 · External reference
Longitudinal evolution of non‐motor symptoms in early Parkinson's disease: a 3‐year prospective cohort study
10.1038/s41531-021-00207-5 · 2021 · External reference
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
10.1002/acn3.51022 · 2020 · External reference
The Parkinson progression marker initiative (PPMI)
10.1016/j.pneurobio.2011.09.005 · 2011 · External reference
Neuropsychiatric symptoms in Parkinson's disease
10.1002/mds.22589 · 2009 · External reference
A statement of the MDS on biological definition, staging, and classification of Parkinson's disease
10.1002/mds.29683 · 2023 · External reference
Are we ready for a biological diagnosis of Parkinson's disease?
10.1038/s41419-025-08076-z · 2025 · External reference
Defining Parkinson's disease: past and future
10.3233/jpd-230411 · 2024 · External reference
SynNeurGe: the road ahead for a biological definition of Parkinson's disease
10.1177/1877718x241298194 · 2025 · External reference
The Parkinson's progression markers initiative (PPMI) ‐ establishing a PD biomarker cohort
10.1002/acn3.644 · 2018 · External reference
Assessment of heterogeneity among participants in the Parkinson's progression markers initiative cohort using alpha‐synuclein seed amplification: a cross‐sectional study
10.1016/s1474-4422(23)00109-6 · 2023 · External reference
The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment
10.1111/j.1532-5415.2005.53221.x · 2005 · External reference
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
10.1371/journal.pone.0175674 · 2017 · External reference
The MoCA: well‐suited screen for cognitive impairment in Parkinson disease
10.1212/wnl.0b013e3181fc29c9 · 2010 · External reference
Unresolved reference
1986 · External reference
Test characteristics of the 15‐item geriatric depression scale and Hamilton depression rating scale in Parkinson's disease
10.1097/01.jgp.0000192488.66049.4b · 2006 · External reference
Unresolved reference
1970 · External reference
Some norms and reliability data for the state‐trait anxiety inventory and the Zung self‐rating depression scale
10.1111/j.2044-8260.1983.tb00610.x · 1983 · External reference
A new method for measuring daytime sleepiness: the Epworth sleepiness scale
10.1093/sleep/14.6.540 · 1991 · External reference
The REM sleep behavior disorder screening questionnaire ‐ a new diagnostic instrument
10.1002/mds.21740 · 2007 · External reference
Validation of the questionnaire for impulsive‐compulsive behaviors in Parkinson's disease (QUIP)
10.1002/mds.22571 · 2009 · External reference
Movement Disorder Society‐sponsored revision of the unified Parkinson's disease rating scale (MDS‐UPDRS): scale presentation and climimetric testing results
10.1002/mds.22340 · 2008 · External reference
Unresolved reference
2022 · External reference
Unresolved reference
2009 · External reference
Unresolved reference
2004 · External reference
Silhouettes: a graphical aid to the interpretation and validation of cluster analysis
10.1016/0377-0427(87)90125-7 · 1987 · External reference
Adjusting for multiple testing: when and how?
10.1016/s0895-4356(00)00314-0 · 2001 · External reference
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case‐control study
10.1002/1531-8257(200007)15:4<669::aid-mds1011>3.0.co;2-5 · 2000 · External reference
Non‐motor symptoms of Parkinson's disease: diagnosis and management
10.1016/s1474-4422(06)70373-8 · 2006 · External reference
Non‐motor symptoms in Parkinson's disease
10.1016/j.parkreldis.2015.09.004 · 2016 · External reference
Progression in Parkinson's disease: variation in motor and non‐motor symptoms severity and predictors of decline in cognition, motor function, disability, and health‐related quality of life as assessed by two different Methods
10.1002/mdc3.13262 · 2021 · External reference
MDS research criteria for prodromal Parkinson's disease
10.1002/mds.26431 · 2015 · External reference
Update of the MDS research criteria for prodromal Parkinson's disease
10.1002/mds.27802 · 2019 · External reference
REM sleep behavior disorder and cognitive impairment in Parkinson's disease
10.1093/sleep/zsx101 · 2017 · External reference
Association between REM sleep behavior disorder and cognitive dysfunctions in Parkinson's disease: a systematic review and meta‐analysis of observational studies
10.3389/fneur.2020.577874 · 2020 · External reference
Comorbidity of the nonmotor symptoms of Parkinson's disease
10.1002/mds.1099 · 2001 · External reference
A 12‐year population‐based study of psychosis in Parkinson disease
10.1001/archneurol.2010.166 · 2010 · External reference
Prevalence and characteristics of dementia in Parkinson disease: an 8‐year prospective study
10.1001/archneur.60.3.387 · 2003 · External reference
Impulse control and related disorders in Parkinson's disease
10.1159/000341996 · 2013 · External reference
Long‐term dementia risk in Parkinson disease
10.1212/wnl.0000000000209699 · 2024 · External reference
Hallucinations in Parkison's disease: prevalence, phenomenology and risk factors
10.1093/brain/123.4.733 · 2000 · External reference
Relationship between hallucinatons, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease
10.1002/mds.20582 · 2005 · External reference
Dopamine agonists and risk: impulse control disorders in Parkinson's disease
10.1093/brain/awr080 · 2011 · External reference
Circadian and sleep disorders in Parkinson's disease
10.1016/j.expneurol.2012.08.018 · 2013 · External reference
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire
10.1002/mds.22868 · 2010 · External reference